EA200200665A1 - NEW COMPOUNDS OF BENZOLSULFONAMIDE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

NEW COMPOUNDS OF BENZOLSULFONAMIDE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
EA200200665A1
EA200200665A1 EA200200665A EA200200665A EA200200665A1 EA 200200665 A1 EA200200665 A1 EA 200200665A1 EA 200200665 A EA200200665 A EA 200200665A EA 200200665 A EA200200665 A EA 200200665A EA 200200665 A1 EA200200665 A1 EA 200200665A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
benzolsulfonamide
receiving
pharmaceutical compositions
compositions containing
Prior art date
Application number
EA200200665A
Other languages
Russian (ru)
Other versions
EA005403B1 (en
Inventor
Жильбер Лавиелль
Бернар Симитьер
Тони Вербёрен
Серж Симоне
Кристин Вессетт-Курше
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200200665A1 publication Critical patent/EA200200665A1/en
Publication of EA005403B1 publication Critical patent/EA005403B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

Соединение формулы (I)в которой Rпредставляет собой гидрокси, алкокси, арилокси или арилалкилоксигруппу,А представляет собой группу СН атом азота, в в этом случае Rимеет значение, указанное в описании, или R-A совместно представляют собой атом кислорода или группув которой Rи Rимеют значения, указанные в описании,Rпредставляет собой атом водорода или алкильную группу,Rи R, которые могут быть одинаковыми или различными, каждый представляет собой атом водорода, атом галогена, алкильную группу, алкоксигруппу, гидроксигруппу или тригалоалкильную группу,n представляет собой целое число от 2 до 6 включительно,m и р представляют собой целые числа от 0 до 6 включительно.Лекарственные препараты.The compound of formula (I) in which R1 is a hydroxy, alkoxy, aryloxy or arylalkyloxy group, A represents the CH group nitrogen atom, in this case R1 has the meaning specified in the description, or RA together represent an oxygen atom or groups of which R1 and R7 have the values as indicated in the description, R1 is a hydrogen atom or an alkyl group, R1 and R4, which may be the same or different, each represents a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, a hydroxy group or a trihaloalkyl group group, n is an integer from 2 to 6 inclusive, m and p are integers from 0 to 6 inclusive. Medications.

EA200200665A 2001-07-13 2002-07-12 Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them EA005403B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109338A FR2827287B1 (en) 2001-07-13 2001-07-13 NOVEL BENZENE SULFONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (2)

Publication Number Publication Date
EA200200665A1 true EA200200665A1 (en) 2003-02-27
EA005403B1 EA005403B1 (en) 2005-02-24

Family

ID=8865461

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200665A EA005403B1 (en) 2001-07-13 2002-07-12 Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US6589956B2 (en)
EP (1) EP1275644A1 (en)
JP (1) JP4138382B2 (en)
KR (1) KR100498864B1 (en)
CN (1) CN1168715C (en)
AR (1) AR036340A1 (en)
AU (1) AU2002300093B2 (en)
BR (1) BR0202674A (en)
CA (1) CA2394037C (en)
EA (1) EA005403B1 (en)
FR (1) FR2827287B1 (en)
HK (1) HK1050681A1 (en)
HU (1) HUP0202286A2 (en)
MX (1) MXPA02006852A (en)
NO (1) NO323868B1 (en)
NZ (1) NZ520140A (en)
PL (1) PL354948A1 (en)
ZA (1) ZA200205598B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4324221B2 (en) * 2005-08-26 2009-09-02 株式会社医薬分子設計研究所 Derivatives having PPAR agonist activity
US10093640B2 (en) 2012-09-21 2018-10-09 Vanderbilt University Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
EP3038618B1 (en) 2013-08-28 2020-10-14 Vanderbilt University Substituted indole mcl-1 inhibitors
CN106456602B (en) 2014-03-27 2020-11-24 范德比尔特大学 Substituted indole MCL-1 inhibitors
US9949965B2 (en) 2014-10-17 2018-04-24 Vanderbilt University Tricyclic indole Mcl-1 inhibitors and uses thereof
KR102396177B1 (en) 2016-03-04 2022-05-09 반더빌트유니버시티 Substituted indole MCL-1 inhibitors
TW202136235A (en) * 2019-12-24 2021-10-01 日商大日本住友製藥股份有限公司 Aliphatic amide derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
KR940007458B1 (en) * 1991-11-21 1994-08-18 주식회사 금성사 Manufacturing method of thin film transistor
TW219358B (en) * 1991-12-20 1994-01-21 Hokuriku Pharmaceutical
WO1994014769A1 (en) * 1992-12-21 1994-07-07 Taisho Pharmaceutical Co., Ltd. N-substituted indole derivative
GB9317764D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
FR2712591B1 (en) * 1993-11-19 1996-02-09 Pf Medicament New arylpiperazines derived from indole, their preparation and their therapeutic use.
AU714054B2 (en) * 1995-01-06 1999-12-16 Toray Industries, Inc. Benzene-fused heterocyclic derivatives and use of the same
US5998415A (en) * 1995-11-02 1999-12-07 Merck Sharp & Dohme Ltd. Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors
GB9523250D0 (en) * 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9523243D0 (en) * 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CA2394037C (en) 2008-04-29
BR0202674A (en) 2003-05-06
JP4138382B2 (en) 2008-08-27
NO20023389L (en) 2003-01-14
US6589956B2 (en) 2003-07-08
AR036340A1 (en) 2004-09-01
PL354948A1 (en) 2003-01-27
HUP0202286A2 (en) 2003-08-28
EA005403B1 (en) 2005-02-24
AU2002300093B2 (en) 2007-07-12
MXPA02006852A (en) 2005-07-25
US20030109533A1 (en) 2003-06-12
ZA200205598B (en) 2003-03-27
KR20030007173A (en) 2003-01-23
HU0202286D0 (en) 2002-09-28
NO20023389D0 (en) 2002-07-12
FR2827287B1 (en) 2003-10-31
NZ520140A (en) 2003-09-26
HK1050681A1 (en) 2003-07-04
CN1397550A (en) 2003-02-19
NO323868B1 (en) 2007-07-16
CN1168715C (en) 2004-09-29
KR100498864B1 (en) 2005-07-04
CA2394037A1 (en) 2003-01-13
JP2003064055A (en) 2003-03-05
EP1275644A1 (en) 2003-01-15
FR2827287A1 (en) 2003-01-17

Similar Documents

Publication Publication Date Title
EA200000327A2 (en) NEW CONNECTIONS OF AMINOTRIAZOL, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
MY138145A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
CY1106858T1 (en) NEW CYCLIC AMIDE DERIVATIVES
HUP0001192A2 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
MXPA05010638A (en) Cement additive.
ES2188280T3 (en) ACETALES HETEROARIL-CICLICOS.
EA199800768A1 (en) NEW ERYTHROMYCIN DERIVATIVES, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS MEDICAL DOCUMENTS
NO990583L (en) Cyclic ether compounds as sodium channel modulators
HUP0402235A2 (en) 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof, and pharmaceutical compositions containing them
ATE497948T1 (en) BICYCLIC COMPOUNDS
EA200100090A2 (en) New piperide-4-sulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
EA200200665A1 (en) NEW COMPOUNDS OF BENZOLSULFONAMIDE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0201357A2 (en) Asymmetric copper complex, its preparation and process for preparing cyclopropan carboxylate derivatives using the same
EP1420010A4 (en) Amphoteric lipid compound and use thereof
HUP0004588A2 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
EA200100059A3 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
ATE173727T1 (en) SUBSTITUTED QUINOLINES FOR THE TREATMENT OF LEISMANIOSIS
ATE314352T1 (en) ANILIDES AS ACAT INHIBITORS
EA200200611A1 (en) NEW TETRAHYDROPYRIDINES, METHOD FOR THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
DK0754185T3 (en) Process for Preparation of 7-Trialkylsilyl-Baccatin III
EA200101230A1 (en) NEW INHIBITORS OF METALLOPROTEASIS, THEIR METHOD OF OBTAINING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
EA200300458A1 (en) NEW CONNECTIONS OF AMINOTRIAZOLONE, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0301553A2 (en) Pharmaceutical compositions and their use for treating neurological disorders
EA200200807A1 (en) AMINO ACID COMPOUNDS AND THEIR APPLICATION AS NEP, ACE AND ECE INHIBITORS
ATE380173T1 (en) METHOD FOR PRODUCING (2S,3R,4S)-4-HYDROXYISOLEUCINE AND ANALOGS

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU